The National Institutes of Health (NIH) is offering a funding opportunity through the RFA-CA-24-010 Notice of Funding Opportunity (NOFO) for exploratory research projects focused on innovative biospecimen science technologies relevant to cancer research. The objective is to develop new tools and methodologies that enhance the quality of cancer biospecimens, specifically addressing pre-analytical degradation issues during collection and processing to improve sample integrity for downstream analyses. This initiative is crucial for advancing cancer biology, early detection, and treatment methodologies, ultimately aiming to reduce health disparities associated with cancer research. Interested applicants can apply for grants with a maximum budget of $150,000 per year over three years, with a total anticipated funding amount of $1,000,000 for four awards. The application period opens on March 1, 2024, and closes on October 1, 2024. For more information, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-010.html.